SEC 13F Intelligence

Global Imc LLC / ASND

Global Imc LLC’s Ascendis Pharma A/S Position

Does Global Imc LLC own Ascendis Pharma A/S (ASND)? Not currently — the last reported position was 23.0K shares worth $3M in Q2 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q2 2019
Shares
23.0K
% of Portfolio
+1.13%
Quarters Held
2
position exited

Position History ASND

Reported value by quarter
Q1 ’19: $3MQ1 ’19Q2 ’19: $3MQ2 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q2 201923.0K$3M+1.13%
Q1 201925.5K$3M+1.33%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Global Imc LLC’s full portfolio or all institutional holders of ASND.